Mascaro JM: Considerations on fibro-epithelial tumors. Exocrine syringofibradenoma. Ann Dermatol Syphiligr (Paris) 90: 143, 1963.
Jowker F, Naseri M, Aslani F: An unusual presentation and a new treatment of eccrine syringofibroadenoma. J Pak Assoc Derma 16: 112, 2006.
Ahcar A, Naskar B, Chatterjee G, et al: Eccrine syringofibroadenoma: an unusual presentation of a rare disease. J Pak Assoc Derma 21: 58, 2011.
Starink TM: Eccrine syringofibroadenoma: multiple lesions representing a new cutaneous marker of the Schöpf syndrome, and solitary nonhereditary tumors. J Am Acad Dermatol 36: 569, 1997.
Utani A, Yabunami H, Kakuta T, et al: Reactive eccrine syringofibroadenoma: an association with chronic foot ulcer in a patient with diabetes mellitus. J Am Acad Dermatol 41: 650, 1999.
Arora P, Bansal S, Garg VK, et al: Solitary eccrine syringofibroadenoma with nail involvement: a rare entity. Indian J Dermatol 60: 103, 2015.
First described in 1963, eccrine syringofibroadenoma (ESFA) is a rare benign tumor that proliferates with differentiation toward ductal eccrine structures. There are many clinical presentations, including plaques, papules, verrucous plaques, keratotic tumors, and solitary tumors. The age of onset varies, with presentation between 16 and 80 years; however, solitary lesions are seen most commonly in the seventh and eighth decades. Here, we present the case of a 72-year-old woman referred to our outpatient clinic with a nodule on her leg. The histopathology result was ESFA. The lesion regressed after six cryotherapy sessions. Physicians should consider the possibility of ESFA and must remember its malignant potential in elderly patients.